Chowdhury et al. [17] demonstrated that the deficiency of bone morphogenetic protein receptor type II caused cell‐specific effects, including increasing the expression of Bcl‐XL transcripts in PASMCs while inhibiting it in ECs in PAH. This evidence concerns the gene BCL2L1 and pulmonary arterial hypertension.